Make Smarter Investment Decisions Every Day.
163 guides · 15+ calculators · daily briefFree daily brief, 163 deep guides, and 15+ calculators — trusted by serious investors.
- Real-time data
- No spam, unsubscribe anytime
- Updated daily
Ask anything about investing — answered from 163+ analyses and 1,000+ terms, with sources
Gold and Stocks Can Rally Together: Why “Risk-On vs Safe-Haven” Is Too Simple
Gold and the S&P 500 both rose on October 6, 2026. See why the risk-on vs safe-haven label is too simple, and which shared macro drivers moved both assets.
What Is an ETF? A Beginner's Guide to Exchange-Traded Funds
What is an ETF? Learn how exchange-traded funds work, how a small expense ratio adds up over 30 years, how to buy an ETF, and the main risks to understand.
Stocks Slip as Tech, Healthcare Weigh; Citi Falls on Earnings
WhyU.S. equities closed slightly lower as sector weakness in healthcare and technology offset mixed earnings results; Citigroup fell 4% despite beating Wall Street estimates, while healthcare stocks declined in late afternoon trading.
- Major indexes slipped; S&P 500 down 0.02%, Nasdaq off 0.15%, Dow fell 0.35%
- Small caps underperformed; Russell 2000 fell 0.84%
- VIX rose 3.2% to 15.32 as caution crept into markets
- Next
- CPI inflation · Wed, Oct 14 · 8:30 AM ET
- AAPL▲ +0.09%· via Yahoo
Apple Inc (AAPL) gains 0.09% as analysts discuss smart home product strategy
Apple Inc (AAPL) common stock rose 0.09% to $341.27. Yahoo Finance Technology Editor Dan Howley discussed the company's latest smart home products and its competitive position against Google and Amazon. The stock sits at 93.4% of its 52-week range.
- INTC▲ +1.44%· via Yahoo
Intel Corp Rises 1.44% as Supreme Court Retirement Plan Case Draws Attention
Intel Corp (INTC) common stock gained 1.44% to close at $102.81. Chris Tobe, Chief Investment Officer at The Hackett Group, discussed a Supreme Court case involving Intel Corp (INTC) and retirement plan fiduciary issues on the Broadcast Retirement Network. The stock has returned 168.12% over the past year.
- PFE▼ -0.11%· via Yahoo
Pfizer edges lower as company announces drug discovery collaboration with Enodia
Pfizer Inc (PFE) fell 0.11% to $28.37 in the session. The pharmaceutical company entered a research collaboration and licensing agreement with Enodia Therapeutics to develop small molecule drugs targeting Sec61, with Pfizer handling clinical, regulatory, and commercial development. The stock has gained 12.52% over the past year.
Defensive sectors led as utilities and staples gained while tech and industrials lagged
What Is a Dividend? How Dividends Work and How You Get Paid
What Is a 401(k) and How Does the Employer Match Work?
Yields Hit 2007 Highs: Why Is the Nasdaq Near Records?
Master the fundamentals. From foundational literacy to professional market analysis.
Every financial term explained. From basics to advanced market concepts.
Every number on Money365.Market is sourced — see how we source our data.